Sd-021, derivatives of decursin, inhibits tumorigenesis in NSCLC by inhibiting the EGFR/STAT3 signaling pathway

Abstract Lung cancer, particularly non-small cell lung cancer (NSCLC), remains a significant challenge in oncology despite advances in targeted and immune-based therapies. NSCLC accounts for approximately 85% of all lung cancer cases, with five-year survival rates ranging from 4 to 17%, depending on...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hyun-Ha Hwang, Jeong-Hui Je, Hyeong-Chan Lee, Ji-Sung Yoo, Taehyoun Kim, Jung Hwan Choi, Jin Won Hong, Hae-In Lim, Ga Yoon Kim, Yun-Beom Sim, Kwang-Jin Cho, Eun-wook Choi, Chunhoo Cheon, Jae Yeol Lee, Seong-Gyu Ko
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2025-07-01
Col·lecció:	Scientific Reports
Matèries:	Sd-021 Decursin derivatives Non-small cell lung cancer (NSCLC) EGFR/STAT3 signaling pathway
Accés en línia:	https://doi.org/10.1038/s41598-025-05715-5
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!